Physician
Cardiology
Dr. Paul A. Reilly, MD
|
|
Give Review
Dr. Paul A. Reilly is an expert in the field of Cardiology. He researched medicine at Manila Central University College of Medicine. He over the years received 1 awards: "CMS Meaningful Use Stage 1 Certification". Paul Reilly is also a published physician. He has 25 paper published. The most recent paper is: Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis. Paul A. Reilly accepts Medicare.
Publications
- Dabigatran etexilate and reduction in serum apolipoprotein B.
- Dabigatran Etexilate in Atrial Fibrillation Patients with Severe Renal Impairment: Dose Identification Using Pharmacokinetic Modeling and Simulation.
- Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversion.
- Dabigatran etexilate: future directions in anticoagulant treatment.
- Rationale and design of RE-LY: randomized evaluation of long-term anticoagulant therapy, warfarin, compared with dabigatran.
- Dabigatran with or without concomitant aspirin compared with warfarin alone in patients with nonvalvular atrial fibrillation (PETRO Study).
- Risks for stroke, bleeding, and death in patients with atrial fibrillation receiving dabigatran or warfarin in relation to the CHADS2 score: a subgroup analysis of the...
- Efficacy and safety of dabigatran vs. warfarin in patients with atrial fibrillation--sub-analysis in Japanese population in RE-LY trial.
- One step forward in engaging clinicians in IT.
- Dabigatran versus warfarin in patients with atrial fibrillation.
- Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an...
- Newly identified events in the RE-LY trial.
- Dabigatran compared with warfarin in patients with atrial fibrillation and previous transient ischaemic attack or stroke: a subgroup analysis of the RE-LY trial.
- Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation.
- Risk of bleeding with 2 doses of dabigatran compared with warfarin in older and younger patients with atrial fibrillation: an analysis of the randomized evaluation of ...
- Efficacy and Safety of Dabigatran Compared to Warfarin in Patients With Paroxysmal, Persistent, and Permanent Atrial Fibrillation: Results From the RE-LY (Randomized E...
- Population pharmacokinetic analysis of the oral thrombin inhibitor dabigatran etexilate in patients with non-valvular atrial fibrillation from the RE-LY trial.
- Myocardial Ischemic Events in Patients With Atrial Fibrillation Treated With Dabigatran or Warfarin in the RE-LY (Randomized Evaluation of Long-Term Anticoagulation Th...
- Pharmacokinetics and pharmacodynamics in Japanese and Caucasian subjects after oral administration of dabigatran etexilate.
- Telmisartan plus hydrochlorothiazide versus telmisartan or hydrochlorothiazide monotherapy in patients with mild to moderate hypertension: a multicenter, randomized, d...
- The efficacy and safety of telmisartan compared to enalapril in patients with severe hypertension.
- Combination treatment with telmisartan and hydrochlorothiazide in black patients with mild to moderate hypertension.
- Dipyridamole preserved platelets and reduced blood loss after cardiopulmonary bypass.
- Extended cervicomediastinal thymectomy in the integrated management of myasthenia gravis.
Doctors Specialties
- Internal Medicine
- Cardiology
Accepted Insurances
Awards
- CMS Meaningful Use Stage 1 Certification
Education
-
Manila Central University College of Medicine
Drug Facts
| NPI NUMBER | 1811962319 | |
| NPPES Provider LastName | REILLY | |
| NPPES Provider FirstName | PAUL | |
| NPPES Provider ZIPCode | 150686015 | |
| NPPES Provider State | PA | |
| Specialty Description | Internal Medicine | |
| Total Claim Count | 10616.0 | |
| Distinct Opioid Count | 9.0 | |
| Opioid Claim Count | 663.0 | |
| Percent Opioid Claims | 6.25 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1811962319 |
| Last Name Of The Provider | REILLY |
| First Name Of The Provider | PAUL |
| View All |
Similar Doctors
|
|
Dr. Jamal M. Aljari, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Thomas R. Litz, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Simran Khurana, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Daniel R. Casper, MD
This Doctor is OpenDoctor Recommended.
|